Patents by Inventor Syntonix Pharmaceuticals, Inc.

Syntonix Pharmaceuticals, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia
    Publication number: 20130273047
    Abstract: The invention relates to a chimeric protein comprising at least one clotting factor and at least a portion of an immunoglobulin constant region. The invention relates to a method of treating a hemostatic disorder comprising administering a therapeutically effective amount of a chimeric protein wherein the chimeric protein comprises at least one clotting factor and at least a portion of an immunoglobulin constant region.
    Type: Application
    Filed: March 11, 2013
    Publication date: October 17, 2013
    Applicant: SYNTONIX PHARMACEUTICALS, INC.
    Inventor: SYNTONIX PHARMACEUTICALS, INC.
  • Immunoglobulin Chimeric Monomer-Dimer Hybrids
    Publication number: 20130171138
    Abstract: The invention relates to a chimeric monomer-dimer hybrid protein wherein said protein comprises a first and a second polypeptide chain, said first polypeptide chain comprising at least a portion of an immunoglobulin constant region and a biologically active molecule, and said second polypeptide chain comprising at least a portion of an immunoglobulin constant region without the biologically active molecule of the first chain. The invention also relates to methods of using and methods of making the chimeric monomer-dimer hybrid protein of the invention.
    Type: Application
    Filed: November 2, 2012
    Publication date: July 4, 2013
    Applicant: Syntonix Pharmaceuticals, Inc.
    Inventor: Syntonix Pharmaceuticals, Inc.